-
Cefodizime: From Spectrum to AMR Assay Design
2026-09-15
Cefodizime is a third-generation cephalosporin antibiotic with a valuable but selective activity profile for antimicrobial research. This article connects its PBP mechanism and resistance boundaries with findings from urban-rodent surveillance to improve AMR assay design and interpretation.
-
FITC Goat Anti-Rabbit IgG (H+L) Antibody
2026-09-15
A scenario-based guide to using FITC Goat Anti-Rabbit IgG (H+L) Antibody, SKU K1203, in fluorescence workflows supporting cell viability, proliferation, cytotoxicity, and biomarker studies. It covers assay design, controls, storage, interpretation, and practical vendor-selection criteria.
-
Multiomics Maps Acute Liver Injury Therapies
2026-09-14
The reference study combines co-expression modules, regulatory-network analysis, transcriptomics, and proteomics to compare bifendate with muaddil sapra in CCl4-induced acute liver injury. Its main contribution is a systems-level view showing that the two treatments influence overlapping injury modules through partly distinct RNA, transcription-factor, and protein signatures.
-
Reserpine (N1867): Practical Lab Workflow Guide
2026-09-14
This guide explains how to handle Reserpine (SKU N1867) for neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology research when direct matched paper evidence is unavailable. It covers identity checks, DMSO-based preparation, storage, QC, and experimental boundaries; the compound is for research use only and not for diagnostic or medical applications.
-
H2S Deficiency and ER Stress in Diabetic Cardiomyopathy
2026-09-13
Guo et al. identified reduced endogenous hydrogen sulfide production as a mechanistic component of palmitate-associated myocardial injury in diabetic cardiomyopathy. By combining patient samples, a streptozotocin-induced rat model, and AC16 cardiomyocytes, the study connected H2S deficiency with lipid accumulation, apoptosis, and endoplasmic reticulum stress, while showing that H2S donation or ER-stress inhibition reduced these injury phenotypes.
-
Methicillin Sodium Salt in MSSA Research
2026-09-12
Build reproducible MSSA susceptibility assays, gram-positive infection models, and resistance comparisons with Methicillin sodium salt. The workflow also shows how to connect phenotypic antibiotic data with target-focused screening without confusing MSSA activity with MRSA or Mycobacterium tuberculosis mechanisms.
-
Cefiderocol Activity Against Resistant Enterobacterales
2026-09-12
This multicountry European study evaluated cefiderocol against 1,909 Enterobacterales isolates, including organisms resistant to meropenem and established β-lactam/β-lactamase inhibitor combinations. Cefiderocol showed high in vitro susceptibility overall and retained activity against many highly resistant isolates, while genomic analysis linked cefiderocol resistance to combinations of iron-uptake, carbapenemase, and ftsI alterations.
-
Cinoxacin: In Vitro Findings from the 1975 Study
2026-09-11
The reference study established a systematic in vitro profile of Cinoxacin against clinical aerobic Gram-negative isolates, combining susceptibility testing, disk diffusion, bactericidal assays, and resistance selection. Its findings provide a historical evidence base for interpreting Cinoxacin MIC values and designing urinary tract infection research and antibiotic resistance studies.
-
Cy5 amine (non-sulfonated): Labeling Guide
2026-09-11
Cy5 amine (non-sulfonated), SKU A8143, provides a primary amino group for covalent attachment to activated biomolecules while offering red/far-red fluorescence near 662 nm. It must be dissolved in DMSO or ethanol before transfer into a compatible aqueous labeling workflow and is intended for research use, not diagnostic or medical applications.
-
Methicillin Sodium Salt as a Translational Benchmark
2026-09-10
A mechanistic and strategic guide to using Methicillin sodium salt as a benchmark for Staphylococcus aureus susceptibility, resistance biology, gram-positive infection models, and translational antibiotic development.
-
BHQ (2,5-di-tert-butylbenzene-1,4-diol) Workflow Guide
2026-09-10
Learn how BHQ converts SERCA inhibition into measurable calcium-store depletion, capacitative calcium entry, and pathway-level biology. This practical guide connects calcium signaling research with vascular physiology and the emerging HSC-mobilization application while emphasizing controls, workflow design, and troubleshooting.
-
Arachidonic Acid for Reproducible Cell Assays
2026-09-09
Learn how Arachidonic Acid (SKU C4223) can help researchers design more interpretable viability, proliferation, and inflammation assays. This scenario-based guide covers lipid signaling, solvent compatibility, concentration planning, data interpretation, and practical product selection.
-
Ceftolozane/Tazobactam: Evidence and Clinical Relevance
2026-09-09
The reference review examines ceftolozane/tazobactam as an antipseudomonal cephalosporin/β-lactamase inhibitor combination designed to address resistant gram-negative infections. Its principal contribution is an integrated analysis of antibacterial mechanisms, pharmacokinetics, pharmacodynamics, resistance, clinical trial evidence, dosing, and safety for complicated intraabdominal and urinary tract infections.
-
GlycoRNA–RBP Nanodomains and TAT Entry
2026-09-08
The reference preprint presents evidence that cell-surface RNA-binding proteins and glycoRNAs organize into extracellular nanoclusters that support entry of the cell-penetrating peptide TAT. Its perturbation-based design links surface RNA, cluster integrity, and peptide internalization, expanding conventional models of plasma-membrane organization while leaving the molecular anchoring mechanism open.
-
Haloprogin: Evidence from a 1970 Topical Antifungal Study
2026-09-08
The 1970 reference study established Haloprogin as a topical antifungal with dermatophyte activity comparable to tolnaftate, while identifying additional activity against Candida species and selected Gram-positive bacteria. Its combination of serial-dilution testing, fungicidal confirmation, and guinea pig infection models provides a useful evidence framework for contemporary dermatophytosis and topical antimicrobial research.